CIBC Private Wealth Group
TCRT icon

CIBC Private Wealth Group’s Alaunos Therapeutics TCRT Stock Holding History

CIBC Private Wealth Group’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$969 Hold
300
– – ﹤0.01% 2924
2025
Q3 		$723 Hold
300
– – ﹤0.01% 2856
2025
Q2 		$1.46K Hold
300
– – ﹤0.01% 2712
2025
Q1 		$753 Hold
300
– – ﹤0.01% 2850
2024
Q4 		$555 Hold
300
– – ﹤0.01% 2843
2024
Q3 		$966 Sell
300
-1,167
-80% -$4.19K ﹤0.01% 2914
2024
Q2 		$9.35K Hold
1,467
– – ﹤0.01% 2317
2024
Q1 		$25.7K Buy
1,467
+1,134
+341% +$22.7K ﹤0.01% 1950
2023
Q4 		$3.54K Sell
333
-3
-0.9% -$36 ﹤0.01% 1140
2023
Q3 		$6.64K Hold
336
– – ﹤0.01% 1073
2023
Q2 		$25.7K Hold
336
– – ﹤0.01% 868
2023
Q1 		$31.8K Buy
336
+133
+66% +$12.7K ﹤0.01% 871
2022
Q4 		$20 Hold
203
– – ﹤0.01% 850
2022
Q3 		$52K Sell
203
-74
-27% -$21.5K ﹤0.01% 889
2022
Q2 		$51K Hold
277
– – ﹤0.01% 969
2022
Q1 		$27K Hold
277
– – ﹤0.01% 1084
2021
Q4 		$45K Buy
277
+2
+0.7% +$440 ﹤0.01% 1002
2021
Q3 		$75K Buy
275
+3
+1% +$917 ﹤0.01% 917
2021
Q2 		$108K Hold
272
– – ﹤0.01% 1012
2021
Q1 		$147K Sell
272
-7
-3% -$4.36K ﹤0.01% 1007
2020
Q4 		$106K Buy
279
+128
+85% +$50.9K ﹤0.01% 961
2020
Q3 		$57K Buy
+151
New +$66.7K ﹤0.01% 867
2018
Q3 		– Sell
-11
Closed -$5K – 1644
2018
Q2 		$5K Sell
11
-121
-92% -$76.7K ﹤0.01% 1729
2018
Q1 		$78K Buy
132
+6
+5% +$3.74K ﹤0.01% 1070
2017
Q4 		$78K Buy
+126
New +$90.5K ﹤0.01% 1079

Other funds holding TCRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIBC Private Wealth Group's TCRT Position: Q4 2025 in Review

CIBC Private Wealth Group held its Alaunos Therapeutics (TCRT) position steady in Q4 2025 at 300 shares worth $969. The position accounts for ﹤0.01% of the portfolio, ranked #2924.

CIBC Private Wealth Group first reported a position in TCRT in Q4 2017 and has held it in 25 quarters since. The position peaked at $147K in Q1 2021. 27 funds tracked by Wall St. Rank hold TCRT as of Q4 2025.

  • CIBC Private Wealth Group held 300 shares of Alaunos Therapeutics worth $969 as of Q4 2025.
  • CIBC Private Wealth Group left its Alaunos Therapeutics share count unchanged in Q4 2025.
  • Alaunos Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2924 holding.
  • CIBC Private Wealth Group first reported a position in Alaunos Therapeutics in Q4 2017 and has held it in 25 quarters since.
  • CIBC Private Wealth Group's Alaunos Therapeutics position peaked at $147K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.